TrialEuropean journal of pediatrics2025

Safety and effectiveness of a biosimilar somatropin (Cinnatropin®) in children and adolescents receiving growth hormone therapy over 1 year: a registry-based phase IV study.

Ali Rabbani et al.PubMed ↗Publisher ↗

No numbers read from the abstract.